Inhibrx Biosciences, Inc. beat EPS estimates 100% of the time across 2 reported quarters (2 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-2.50 | $-2.34 | +6.4% | Beat |
| Q12026 FY2026 | $-2.37 | $-2.15 | +9.3% | Beat |
| Q42025 FY2025 | — | $-2.11 | — | Miss |
Back to INBX overview · INBX holders · INBX KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.